GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human CYP3A4 bound to an inhibitor

Analyse Crystal structure of human CYP3A4 bound to an inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6BDH
Type
protein
Length
439 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytochrome P450 3A4
EC
1.14.13.-, 1.14.13.157, 1.14.13.32, 1.14.14.1, 1.14.13.67, 1.14.13.97
UniProt
P08684
Ligands
HEM, DEV
Pockets
4 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytochrome P450 3A4 (EC 1.14.13.-, 1.14.13.157, 1.14.13.32, 1.14.14.1, 1.14.13.67, 1.14.13.97)protein43950% helix, 10% strandP08684

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · chains A
  • DEV · tert-butyl [(2S)-1-{[(2S)-3-oxo-2-(phenylamino)-3-{[(pyridin-3-yl)methyl]amino}propyl]sulfanyl}-3-phenylpropan-2-yl]carbamate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19650.850.8591HEM, DEV
21240.480.7829empty
31950.460.7428empty
4510.290.7513empty

Compared structures

  • 6BDH · Crystal structure of human CYP3A4 bound to an inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P08684 · AlphaFold monomer V2.0 prediction for cytochrome P450 3A4 (P08684) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.